AstraZeneca
This role leads a connected evidence strategy spanning R&D through patient care, leveraging AI and multimodal data to shape oncology trials, filings, and access strategies. The position involves owning the end-to-end evidence agenda, prioritizing evidence gaps, and partnering with Translational Science and Clinical Development to advance portfolio decisions. Success requires influencing senior stakeholders in a matrixed environment to scale reusable capabilities and drive adoption across the enterprise.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Principal/Associate Director
Cytel
Epidemiology and Real‑World Evidence Lead
Digital Biology
Director, Evidence Generation- Research Planning and Methodology
bioMérieux
Vice President of AI Research and Real-World Evidence
Flagship Pioneering, Inc.
Director, Global Epidemiology & Real-World Evidence
shionogi
Real World Evidence Manager
AbbVie